Susquehanna International Group’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Susquehanna International Group’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-89,235	Closed	-$899K	–	14133
2022 Q4	$899K	Buy	89,235 +29,446	+49%	+$294K	﹤0.01%	6417
2022 Q3	$592K	Buy	59,789 +21,161	+55%	+$208K	﹤0.01%	8041
2022 Q2	$379K	Buy	38,628 +20,659	+115%	+$202K	﹤0.01%	8933
2022 Q1	$176K	Buy	17,969 +6,423	+56%	+$62.5K	﹤0.01%	11395
2021 Q4	$112K	Buy	+11,546	New	+$112K	﹤0.01%	12065

Susquehanna International Group's MSAC Position: Q1 2023 in Review

Susquehanna International Group sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 89,235 shares — an estimated $899K sold.

Susquehanna International Group first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $899K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Susquehanna International Group reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Susquehanna International Group sold 89,235 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $899K.
Susquehanna International Group first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Susquehanna International Group's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $899K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.